CYSLTR2 and breast cancer: After treatment with BC, GP, and BC/GP, the expression of CysLTs mRNA, LTB4 mRNA, CysLT1, CysLT2, BLT1, BLT2, and LTA4H were significantly lower than the model group (p < 0.01, Fig. 10a, b).